Abstract:Abstract Background Lung cancer is one of the most common tumors in the world, and metastasis is one of the major causes of tumor-related death in lung cancer patients. Tumor-associated macrophages (TAMs) are a major component of the tumor microenvironment (TME) and are frequently associated with tumor metastasis in human cancers. However, the regulatory mechanisms of TAMs in lung cancer metastasis remain unclear. Methods Single-cell sequencing analysis of lung cancer and normal tissues from public databases and from 14 patients who underwent surgery at Zhongshan Hospital was performed. In vitro co-culture experiments were performed to evaluate the effects of TAMs on lung cancer migration and invasion. Changes in the expression of IL-6, STAT3, C/EBPΒ, and EMT pathway were verified using RT-qPCR, western blotting, and immunofluorescence. Dual luciferase reporter assays and ChIP were used to reveal potential regulatory sites on the transcription factor sets. In addition, the effects of TAMs on lung cancer progression and metastasis were confirmed by in vivo models. Results TAM infiltration is associated with tumor progression and poor prognosis. IL-6 secreted by TAMs can activate the JAK2/STAT3 pathway through autocrine secretion, and STAT3 acts as a transcription factor to activate the expression of C/EBPβ, which further promotes the transcription and expression of IL-6, forming positive feedback loops for IL6-STAT3-C/EBPβ-IL6 in TAMs. IL-6 secreted by TAMs promotes lung cancer progression and metastasis in vivo and in vitro by activating the EMT pathway, which can be attenuated by the use of JAK2/STAT3 pathway inhibitors or IL-6 monoclonal antibodies. Conclusions Our data suggest that TAMs promote IL-6 expression by forming an IL6-STAT3-C/EBPβ-IL6 positive feedback loop. Released IL-6 can induce the EMT pathway in lung cancer to enhance migration, invasion, and metastasis. The use of IL-6-neutralizing antibody can partially counteract the promotion of LUAD by TAMs. A novel mechanism of macrophage-promoted tumor progression was revealed, and the IL6-STAT3-C/EBPβ-IL6 signaling cascade may be a potential therapeutic target against lung cancer. Graphical Abstract IL-6 secreted by TAM acts on itself to promote STAT3 phosphorylation, and pSTAT3 transfers into the nucleus, promotes the expression of C/EBPβ. C/EBPβ is able to further promote IL-6 expression, which forms positive feedback for IL-6 secretion. IL-6 secreted by TAMs acts on lung cancer to promote their metastasis through activation of EMT.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the mechanism of tumor - associated macrophages (TAMs) in the progression of lung cancer, especially the specific mechanism by which TAMs promote the epithelial - mesenchymal transition (EMT), invasion and metastasis of lung cancer cells through secreting IL - 6. Specifically, through single - cell sequencing analysis and in - vivo and in - vitro experiments, the researchers revealed that there is an IL6 - STAT3 - C/EBPβ - IL6 positive - feedback loop in TAMs. This loop promotes the further secretion of IL - 6 by activating the JAK2/STAT3 pathway, thereby enhancing the progression and metastasis ability of lung cancer. In addition, the study also explored whether the use of IL - 6 neutralizing antibodies can inhibit this process, providing a new target for lung cancer treatment. The key findings of the paper include: 1. **The relationship between TAMs and the progression of lung cancer**: Through single - cell RNA sequencing analysis, it was found that the infiltration degree of TAMs in tumor tissues increases with the progression of the tumor, and the high infiltration of TAMs is significantly associated with poor prognosis of patients. 2. **The role of IL - 6 in TAMs**: The expression of IL - 6 gradually increases in normal tissues, early - stage lung cancer and the microenvironment of advanced - stage lung cancer, and TAMs are the main source of IL - 6. 3. **The mechanism by which IL - 6 promotes the progression of lung cancer**: IL - 6 promotes the expression of C/EBPβ by activating the JAK2/STAT3 pathway, and then forms an IL6 - STAT3 - C/EBPβ - IL6 positive - feedback loop, enhances the secretion of IL - 6, and promotes the EMT, invasion and metastasis of lung cancer cells. 4. **The potential therapeutic value of IL - 6 neutralizing antibodies**: The use of IL - 6 neutralizing antibodies can significantly inhibit the malignant phenotype of lung cancer cells induced by TAMs, suggesting that IL - 6 may be a potential therapeutic target. These findings not only enhance the understanding of the mechanism of TAMs in the progression of lung cancer, but also provide a theoretical basis for the development of new lung cancer treatment methods.

IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma

Tumor-associated macrophages induce epithelial-mesenchymal transition and promote lung metastasis in breast cancer by activating the IL-6/STAT3/TGM2 axis

Activation of the IL-4/STAT6 Signaling Pathway Promotes Lung Cancer Progression by Increasing M2 Myeloid Cells

C-Myc/mettl3/linc01006 /LINC01006 Positive Feedback Loop Promotes Migration, Invasion and Proliferation of Non-Small Cell Lung Cancer

IL6/STAT3 Signaling Orchestrates Premetastatic Niche Formation and Immunosuppressive Traits in Lung

Tumor hypoxia enhances Non-Small Cell Lung Cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling.

Tumor-associated macrophages secret exosomal miR-155 and miR-196a-5p to promote metastasis of non-small-cell lung cancer

Tumor‐associated macrophages promote the metastasis and growth of non‐small‐cell lung cancer cells through NF‐κB/PP2Ac‐positive feedback loop

Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6/STAT3 signaling pathway

Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis

JAK/STAT3 Signaling is Required for TGF-β-induced Epithelial-Mesenchymal Transition in Lung Cancer Cells.

IL-6 and TNF-α Promote Metastasis of Lung Cancer by Inducing Epithelial-Mesenchymal Transition

Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression

LAMC2 promotes the proliferation of cancer cells and induce infiltration of macrophages in non-small cell lung cancer

M2‐like tumor‐associated macrophages promote epithelial–mesenchymal transition through the transforming growth factor β/Smad/zinc finger e‐box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma

Tumor‐derived exosomal miR‐19b‐3p facilitates M2 macrophage polarization and exosomal LINC00273 secretion to promote lung adenocarcinoma metastasis via Hippo pathway

PMA Treated THP-1-derived-IL-6 Promotes EMT of SW48 Through STAT3/ERK-dependent Activation of Wnt/β-catenin Signaling Pathway

Tumor-associated Macrophages Derived CCL18 Promotes Metastasis in Squamous Cell Carcinoma of the Head and Neck

ADAMTS16 drives epithelial-mesenchymal transition and metastasis through a feedback loop upon TGF-β1 activation in lung adenocarcinoma

Tumor-associated Macrophages Promote Migration and Invasion Via Modulating IL-6/STAT3 Signaling in Renal Cell Carcinoma

Lung mesenchymal stromal cells influenced by Th2 cytokines mobilize neutrophils and facilitate metastasis by producing complement C3